Non-alcoholic fatty liver disease epidemiology and demographics: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Non alcoholic fatty liver disease}} | {{Non alcoholic fatty liver disease}} | ||
{{CMG}}; {{AE}} {{VKG}} | |||
==Overview== | ==Overview== | ||
Revision as of 18:35, 15 December 2017
|
Non-Alcoholic Fatty Liver Disease Microchapters |
|
Differentiating Non-Alcoholic Fatty Liver Disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case studies |
|
Non-alcoholic fatty liver disease epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Non-alcoholic fatty liver disease epidemiology and demographics |
|
FDA on Non-alcoholic fatty liver disease epidemiology and demographics |
|
CDC on Non-alcoholic fatty liver disease epidemiology and demographics |
|
Non-alcoholic fatty liver disease epidemiology and demographics in the news |
|
Blogs on Non-alcoholic fatty liver disease epidemiology and demographics |
|
Directions to Hospitals Treating Non-alcoholic fatty liver disease |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]
Overview
In the third National Health and Nutrition Examination Survey (NHANES III), the peak prevalence of NAFLD in men occurred in the fourth decade and in the sixth decade for women.NAFLD is associated with visceral obesity and diabetes. It has mirrored the epidemiologic course of obesity in the US and is detected in 73–90% of obese individuals on biopsy. Approximately 1/3 of the usa population are estimated to have NAFL. Through most estimates, NASH accommodates approximately 15% of all NAFLD and 3–5% of the american populace.
Epidemiology and Demographics
Epidemiology
- NAFLD is associated with visceral obesity and diabetes.
- It has reflected the epidemiologic direction of weight problems inside the US and is detected in 73–90% of obese people on biopsy.
- About 1/3 of america population are expected to have NAFL. with the aid of maximum estimates, NASH contains about 15% of all NAFLD and 3–5% of the american populace.
- Hospitalizations for NAFLD have elevated by means of 97%.[1]
Prevalance
- As the prevalence of fatty liver ailment increases, clinicians can have greater equipment at hand for control of this condition.
- We conclude the horizon is vibrant for sufferers and docs who address NAFLD.[2]
Ethinicity
- Hepatic steatosis was found in 45% of hispanics (both men and women), 33% of caucasians (42% of men, 24% of women) and 24% of african-american (23% of men, 24% of women).
- This pattern may hold true in children as well. In a San Diego study of 742 consecutive autopsies of children victims of trauma over 10 years, fatty liver was found in 9.6% of all children, 38% of the obese, 12% of hispanics, 10% of asians, 8.6% of caucasians and 1.5% of african-americans.[3]
References
- ↑ Vizuete J, Camero A, Malakouti M, Garapati K, Gutierrez J (2017). "Perspectives on Nonalcoholic Fatty Liver Disease: An Overview of Present and Future Therapies". J Clin Transl Hepatol. 5 (1): 67–75. doi:10.14218/JCTH.2016.00061. PMC 5411359. PMID 28507929.
- ↑ Vizuete J, Camero A, Malakouti M, Garapati K, Gutierrez J (2017). "Perspectives on Nonalcoholic Fatty Liver Disease: An Overview of Present and Future Therapies". J Clin Transl Hepatol. 5 (1): 67–75. doi:10.14218/JCTH.2016.00061. PMC 5411359. PMID 28507929.
- ↑ Pan JJ, Fallon MB (2014). "Gender and racial differences in nonalcoholic fatty liver disease". World J Hepatol. 6 (5): 274–83. doi:10.4254/wjh.v6.i5.274. PMC 4033285. PMID 24868321.